Because disruption of prepulse inhibition is a behavioral feature used to model one aspect of schizophrenia that is shared by several other disorders (Braff and Geyer, 1990; Paylor and Crawley, 1997), we treated crmp1−/− mice with chlorpromazine, a typical antipsychotic drug. This evidence concerns the gene CRMP1 and schizophrenia.